A M Coelho1, G Cherubini1, A De Stefani1, A Negrin1, R Gutierrez-Quintana2, E Bersan3, J Guevar4. 1. Dick White Referrals (DWR), Veterinary Specialist Centre, Cambridge CB8 0UH, UK. 2. College of Medicine, Veterinary and Life Sciences, School of Veterinary Medicine, University of Glasgow, Glasgow G61 1QH, UK. 3. School of Veterinary Science, Small Animal Teaching Hospital, University of Liverpool, CH64 7TE, Neston, Cheshire, UK. 4. School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Abstract
OBJECTIVES: To assess the prevalence of antibodies to Toxoplasma gondii and Neospora caninum in a population of dogs with a diagnosis of suspected inflammatory meningoencephalitis. MATERIALS AND METHODS: Medical records of three referral centres were reviewed from 2008 to 2016 to identify a cohort of dogs diagnosed and treated for suspected inflammatory meningoencephalitis after testing for evidence of exposure to these pathogens. RESULTS: In our sample of 400 dogs the prevalence for exposure (IgG>1:50) to Toxoplasma gondii was 8/201 (3∙98%). Active infection (IgG titre >1:400 or/and an IgM titre >1:64 and/or positive PCR in CSF) was suspected in 1/400 (0∙25%). The prevalence for exposure [Indirect fluorescent antibody (IFA) titre >1:50] and active infection (IFA titres ≥⃒1:400 and/or positive PCR in CSF) with Neospora caninum were 14/201 (6∙96%) and 9/400 (2∙25%), respectively. CLINICAL SIGNIFICANCE: In view of the low prevalence of protozoan infections, the risk associated with starting immunosuppressive medication in dogs with evidence of inflammatory meningitis or encephalitis in the UK appears low.
OBJECTIVES: To assess the prevalence of antibodies to Toxoplasma gondii and Neospora caninum in a population of dogs with a diagnosis of suspected inflammatory meningoencephalitis. MATERIALS AND METHODS: Medical records of three referral centres were reviewed from 2008 to 2016 to identify a cohort of dogs diagnosed and treated for suspected inflammatory meningoencephalitis after testing for evidence of exposure to these pathogens. RESULTS: In our sample of 400 dogs the prevalence for exposure (IgG>1:50) to Toxoplasma gondii was 8/201 (3∙98%). Active infection (IgG titre >1:400 or/and an IgM titre >1:64 and/or positive PCR in CSF) was suspected in 1/400 (0∙25%). The prevalence for exposure [Indirect fluorescent antibody (IFA) titre >1:50] and active infection (IFA titres ≥⃒1:400 and/or positive PCR in CSF) with Neospora caninum were 14/201 (6∙96%) and 9/400 (2∙25%), respectively. CLINICAL SIGNIFICANCE: In view of the low prevalence of protozoan infections, the risk associated with starting immunosuppressive medication in dogs with evidence of inflammatory meningitis or encephalitis in the UK appears low.
Authors: Rafaela Furioso Ferreira; Rosangela Locatelli Dittrich; Isabelle Bay Zimmermann; Blanka Beer Ljubic; Vladimir Mrljak; Peter David Eckersall Journal: Parasitol Res Date: 2021-08-24 Impact factor: 2.383